Since p97 is closely linked to protein quality control and homeostasis, the pharmaceutical inhibition of p97 has been actively pursued as an anticancer strategy, especially in cancers whose survival depends on cellular protein homeostasis [9]. This evidence concerns the gene VCP and cancer.